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ABSTRACT

EVALUATION OF METHODS FOR ANALYZING GENE-GENE INTERACTION
DATA FOR SURVIVAL OUTCOMES
lie Zhang
May 12,2011
In recent years, a number of computational and statistical problems for identify-

ing SNP-SNP interactions in high dimensional survival data have been studied, and several data mining approaches have been proposed. However, the relative performance of
these methods to detect SNP-SNP interactions has not been thoroughly investigated.
In this study, we directly compared the performance of the four techniques to

detect gene-gene interactions in a recently conducted study of genetic polymorphisms
associated with breast cancer survival and recurrence. Four methods were evaluated for
their ability to detect SNP-SNP interactions: Survival Multifactor Dimensionality Reduction, Cox regression with LJ (Lasso) and LJ-L2 (Elastic Net) penalties, and Random
Survival Forest (RSF). Methods were contrasted on the basis of which SNPs they selected.
The results of this study demonstrate how the methods perform in detecting
gene-gene interactions for survival data, and are useful in informing researchers about
choosing an analysis tool for their own real data applications.
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CHAPTER I
INTRODUCTION

Technological advances are rapidly improving geneticist's ability to detect
genetic factors, which influence individual susceptibility to common human diseases.
Research has shown that genes don't function alone; rather, they constantly interact with
one another. Given the complexity and robustness of biological networks such diseases
are unlikely to be the result of single genetic variants, but instead arise from the joint
interaction of two or more variants acting together.
When we think about the whole biological networks, it is important to consider
epistasis, which refers to the situation where interacting genes, as opposed to a single
gene, influence a trait. The methods to detect and characterize epistasis are critical to
understanding complex diseases, such as Alzheimer's disease, diabetes, cardiovascular
disease, and cancer.
One traditional approach to modeling the relationship between discrete predictors
such as genotypes and discrete clinical outcomes is logistic regressIOn modeling
(Lecessie and Vanhouwelingen, 1992). Logistic regression
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a parametric statistical

approach for relating one or more independent or explanatory variables (e.g. disease
status) that follows a binomial distribution. However, detecting and characterizing
epistatic interactions in datasets containing large numbers of SNPs is challenging. The
1

number of possible interaction terms grows exponentially as each additional main effect
is included in the logistic regression model. Thus, logistic regression is limited in its
ability to deal with interaction data.
In response to this limitation, the multifactor dimensionality reduction (MDR)
(Ritchie et aI., 2001) has been developed as a method for reducing the dimensionality of
multi-locus information, to improve the identification of polymorphism combinations
associated with disease risk. This approach is nonparametric, is free of a specified genetic
model, and is directly applicable to the analysis of case-control and discordant sib-pair
study designs. Both empirical and theoretical studies suggest that MDR has excellent
power for identifying high-order gene-gene interactions and is a promising new approach
for overcoming some of the limitations of logistic regression.
Another machine learning method that has attracted considerable interest is
Random Forests (RF) (Breiman, 2001). It is a technique that builds a forest of
classification trees. Each single tree is grown from a bootstrap sample of the data, and the
final outcome predictions are determined by all trees in the forest. There are several
advantages of the RF method. It can handle a large number of input variables. It is fairly
robust in dealing with genetic data in the presence of high amounts of missing data.
Recently, many researchers have been interested in identifying gene-gene
interactions in high dimensional survival data. Thus, the above methods have been
extended to survival analysis. Survival analysis involves the modeling of time to event
data; in this context, death or failure is considered an "event". Survival analysis attempts
to answer questions such as "What is the fraction of a population that will survive past a
certain time?". To model survival data, there are a few basic tools such as the Kaplan-
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Meier estimate of the survival function (Kaplan and Meier, 1958), the log-rank test for
differences between survival functions (Breslow, 1975), and the Cox proportional
hazards model for modeling the effect of multiple covariates on the hazard rate (Cox,
1972). Although numerous computational and statistical methods for identifying SNPSNP interactions in case-control studies have been studied extensively, the analysis of
SNP-SNP interactions associated with survival data is relatively uninvestigated in the
literature.
In the case that survival outcomes associated with genomic data, we have two

statistical objectives. The first is to identify which of the features (e.g. genes or SNPs) in
the genomic data is individually most associated with the survival outcome, and the
second is build a model which can accurately predict survival times. Several methods
have recently been proposed in the literatures that address the two objectives mentioned
above. One approach is to use penalized Cox regression (Benner et aI., 2010) in such
situations. This method determines a subset of co variates that are the most important ones
for predicting the survival outcome by shrinking unimportant regression coefficients to
zero using penalties on the magnitude of the regression coefficients. Another parametric
approach is the accelerated failure time model, which has been applied in conjunction
with partial least squares and the least absolute shrinkage and selection operator (Lasso)
to predict patient survival times from high-dimensional micro array data (Datta et aI.,
2007). Other, nonparametric approaches include the Survival Multifactor Dimensionality
Reduction algorithm (Survival-MDR) (Qui et aI., 2011), and Random Survival Forests
(RSF) (Ishwaran et aI., 2008). Survival-MDR uses a multifactor dimensionality reduction
algorithm that reduces the N-dimensional space for N-way interactions between SNPs to
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one dimension with two levels ("low risk" and "high risk"). Random Survival Forest is a
technique that builds a forest of classification trees, wherein each single tree is grown
from a bootstrap sample of the data, and predictions of patients with unknown survival
times are determined by aggregation of all the trees in the forest.
In the current thesis, we evaluate the use of penalized Cox regression models,
Survival-MDR, and RSF for detecting gene-gene interactions associated with breast
cancer (BrCa) survival and recurrence. Each method is used to identify important single
nucleotide polymorphisms (SNPs) which contribute to one-, two-, and three-way
interaction models for BrCa survival and recurrence. The rest of this thesis is organized
as follows. In chapter 2, we describe some background methodology for survival analysis
including the Kaplan-Meier estimator, the log-rank test, and the Cox proportional hazards
model. Chapter 3 describes two penalized Cox regression models, Survival-MDR, and
RSF, and also describes the breast cancer dataset used in this research and the data
management technique. Chapter 4 summarizes the findings from using the above four
methods. Chapter 5 gives some concluding remarks and discusses future research.

4

CHAPTER II

BACKGROUND

2.1Kaplan-Meier Estimator
The Kaplan-Meier estimator is a nonparametric estimator of the survival function
for right-censored data. It is also known as product-limit estimator. Let Set} be the
probability that an item from a given population will have a lifetime exceeding t. The
Kaplan-Meier estimator is the nonparametric maximum likelihood estimate of Set}. It is a
product of the form

where t is the ith distinct observed failure time, i=1,2, ... ,D, D is the number of distinct
observed failure times, di is the number of individuals who experience the event of
interest at time t;, and n; is the number of individuals at risk just before time ti.

2.2 Log-rank test
The log-rank test statistic is widely used to compare two independent survival
functions in the presence of censored observations. The test statistic is based on a
normalized sum of the differences between the observed failures and the expected
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failures in either of the treatment groups, and has an asymptotic chi-square distribution
with one degree of freedom.
Let j= 1, ... ,J be the set of distinct times of observed events in either group.
Let N].1 and N 2 J· be the number of subjects which have not yet had an event or been
censored at time jfor groups 1 and 2, respectively, and define N.J = N]J. + N2 1.. For each
time j, letO]; and

02i

be the observed number of events and OJ

= 0li +02i'

Under the

null hypothesis of equal survival functions for subjects in groups 1 and 2, the expected
number of failures at timetis expressed as

The log rank statistic Z2compares each

0li to

its expectation

E]j

under the null hypothesis,

and is defined as
J

Z2

=

(I (0]; - Elj))2
j=]

•

~(O (N]. / N.)(l-N]. / N.)(N. -0.)

L..

J

1

I

I

1

J

I)

N i -l

;=]

The statistic Z2 has an asymptotic chi-squared distribution with one degree of freedom,
under the assumption of the null hypothesis.

2.3 Cox proportional hazard model
The Cox proportional hazards model is commonly used to model survival data. It
is non-parametric in that the baseline hazard function can take an arbitrary form. The
model is as follows:
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p

A(t I xJ

= Ao(t)exp(IxJJ;)
j=l

wherex are covariates, A(t Ix) is the hazard at time t for the ith observation, Ao(t) is the
unspecified baseline hazard function, and fJ is a vector of regression coefficients. The
partial likelihood is given by

L(fJ) =

II

exp(xifJ)
iC,=l I exp(x;fJ)
j:Y}~Y,

where ~ denotes the observed time (either censoring time or event time) for subject i, and
C; is the indicator that the time corresponds to an event (C; = 1 if the event occurred

and C;

=0 if the time is a censoring time ). The log partial likelihood is given by

Parameter estimates

/J in the Cox proportional hazard model are obtained by maximizing

the partial likelihood.
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CHAPTER III

METHODOLOGY

3.1 Penalized likelihood methods
Penalized likelihood methods(Benner et aI., 2010) can be used for determining a
subset of covariates that are the most important for predicting survival times, when we fit
models for survival data on the basis of the Cox proportional hazards model. The
penalized log partial likelihood is given by
p

I(P) -

I

PJ. (I P j

I)

)=1

where I(P) denotes the log partial likelihood, P is the dimension of the parameter p, j is
the index with parameter estimates unequal to zero, and PJ. (I Pj

I)

is the penalty function

with a tuning parameter A. The penalty term on the coefficients will shrink them towards
zero, thus reducing the dimensionality of the problem and increasing the stability of the
solution.
We describe k-way (k= 1, 2, 3) interaction models that capture the relationship
between k genes and the survival outcome. For the one way model, the penalized Cox
regression model will include just main effects. For the two-way model, both main and
two-way interaction effects are considered. For the three-way model, main effects, two-,
and three-way interaction effects are all used to fit the model.
8

In order to determine the most important SNPs for the penalized Cox regression
models, we rank the coefficients by their absolute value. The larger the absolute value,
the more important the SNP.

3.1.1 L1-penalized cox regression
Based on the penalized likelihood methods, Tibshirani (Tibshirani, 1997)
proposed to use the L1-penalized Cox regression model and described a technique, called
the Lasso for "Least absolute shrinkage and selection operator", for parameter estimation.
The L1-penalized Cox model has the following penalty,

By penalizing the coefficients associated with each of the covariates during model fitting,
unimportant coefficient will be shrunk towards zero. Thus, the Lasso can be considered
as a version of automated variable selection, particularly useful for high-dimensional data.

3.1.2 Lrpenalized cox regression
L2 -penalized Cox regression with the ridge penalty

p-i(IPj I)=AP/,

j=l, ... ,p

I

was introduced by Verweij and Van Houwelingen (Verweij and Van Houwelingen, 1994).
The ridge regression shrinks the regression coefficients in a manner similar to lasso
regression, but penalizes the square values instead of the absolute values. Regression
coefficients are not shrunk completely to zero, and thus ridge regression is not a variable
selection algorithm. Rather, the procedure is particularly useful for stabilizing the beta
coefficients when the set of regression variables are highly correlated.
9

3.1.3Elastic Net
Elastic net, which employs a combination of the L)- and L2 -penalties, was
introduced by Zou and Hastie (Zou and Hastie, 2005)

p A, ,..10 (I fJj

I) =A, 1fJj 1+~fJj 2 , j =1, ... , p .

The Elastic Net performs variable selection similarly to the Lasso. But the additional L2 penalty distributes the weight to more variables, such that the Elastic Net tends to select
more variables than the Lasso.

3.1.4 Cross-validation and optimization
The penalized regression models use cross-validation of the log partial likelihood
to assess its predictive ability and determine the optimal values of the tuning parameters
1"1 and A2. The tuning parameters are chosen by maximizing the k-fold cross-validated log
partial likelihood. In our study, we used lO-fold cross-validation. The tuning
parameter A, was chosen by maximizing 10 fold cross-validated log likelihood, while the
tuning parameter ~ for Elastic Net was chosen from the set {O.OOO 1, 0.001, 0.01, 0.1, 1,
1O}.

3.2 Survival Multifactor Dimensionality Reduction (Survival MDR)
Survival MDR is a nonparametric and genetic model-free approach that reduces
the dimensionality of the data when analyzing gene-gene interactions. It is an extension
of the MDR approach developed for case-control data, and is specifically designed to
characterize gene-gene interactions in the presence of right-censored data. The goal of
Survival MDR is to change the representation of the data using a constructive induction
10

algorithm, to make interactions easier to detect. The procedure will be used for both
feature selection and model validation as described next.

3.2.1 Feature selection
The Survival MDR procedure for feature selection is illustrated in Figure 1. For
determining an N-way interaction amongst a pool of SNPs, the algorithm proceeds
through the following three steps for all possible N-way combinations of SNPs.

rt

N SNPs

1
.

N-dimensional
multi locus genotype
combination

Identify high/low risk
genotypes usingthe
log-rank test

"'--------.-'J

Fig. 1 Survival MDR attribution construction

First, N SNPs are selected from the pool of all SNPs. In the second step, the logrank test statistics comparing the survival time distributions with and without each of the
multilocus genotype combinations in the N-way interaction table are calculated. In the
third step, each multifactor cell in the N-dimensional space is classified as either "high
risk," if the log-rank test statistic is positive, or as "low risk," if the log-rank statistic is
negative. Once all the genotype are labeled as either "high risk" or "low risk", the
dimensionality of multi-locus genotype information is reduced to one dimension with two
levels ("low risk" and "high risk").

11

3.2.2 Model validation
Survival MDR uses the log rank test to compare the survival time distributions
between high and low risk groups and uses Z2 as the score to choose the best model
amongst all possible N-way combinations of SNPs. A ten-fold cross-validation procedure
is used to determine the best overall model, involving three steps.
In the first step, the whole dataset is randomly divided into ten equal parts. Nine-

tenths of the data are used as the training set, and the remaining one-tenth of the data are
set aside as an independent testing set. Then Z2 statistic is computed for each N-way
interaction model in the training set.
In the second step, an attribute is created for the independent testing set using the
N SNPs that have the best Z2 score. To reduce the possibility of poor estimates of the

predictive ability due to chance divisions of the data set, the entire procedure
performed 10 times so that each sample is included in the testing set at least once.

Fig 2.Ten-fold cross-validation.

12
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In the third step, for each 10-fold cross-validation, the number of times the same
best set of loci/factors was identified across the 10 data subsets is recorded. The crossvalidation consistency (eVe) is a measure of the number of times a particular set of loci
and/or factors is identified across the cross-validation subsets. There are 10 possible
values of the eve ranging from 1 to 10, where 10 indicate strong evidence in favor of a
multifactor association. The best Survival MDR model was selected as that with the
maximum testing accuracy averaged over the lO-fold cross validation, and also has the
maximum cross-validation consistency (eVe) as described previously. For all of the
selected models, the eve ranged from 8 to 10 are considered as a highly predictive
model.

3.3Random Survival Forests
Random Survival Forests(RSF) are an ensemble tree method for the analysis of
right censored survival data. Standard analyses often rely on restrictive assumptions such
as proportional hazards. This property is especially helpful in survival analysis, and
makes RSFs highly data adaptive. The procedure only requires three parameters to be set
(the number of randomly selected predictors, the number of trees grown, and the splitting
rule used), thus making it quite user-friendly.

3.3.1 The Algorithm
Each tree in the forest is constructed as follows:

13

In the first step, draw B bootstrap samples, with replacement, from the entire data
set. B is the total number of trees in the forest. Each bootstrap sample excludes on
average 37% of the data, called the out-of bag data (OOB data).
In the second step, a survival tree grows for each bootstrap sample. At each node
III

the tree, randomly select m candidate variables for splitting on. The absolute

magnitude of m is a function of the number of variables in the data set and remains
constant throughout the forest building process.
In the third step, split on a variable using one of several survival splitting rules. A
node is split on that variable which maximizes the survival differences between daughter
nodes.
Computation proceeds by iterating the second and third steps until the tree is fully
grown (no pruning).

3.3.2 Splitting rules
Four different splitting rules are available for use with RSF(Ishwaran et aI.,
2008).The log-rank splitting rule, the default splitting rule, splits nodes by maximizing
the log-rank test statistic. In this study, we the analysis under this splitting rule since is a
well-established concept, having been shown to be robust in both proportional and nonproportional hazards settings. Variants on this procedure include the log-rank score rule,
which splits nodes on the basis of a standardized log-rank statistic, and the random logrank splitting rule, which is a fast approximation to the log-rank splitting rule. As an
alternative to the log-rank splitting rules, node splitting can be based instead on the
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conservation-of-events principle. This node splitting rule may help to reduce the potential
bias in the other splitting rules to favor continuous predictors and uneven splits.

3.3.3 Variable importance (VIMP) selection
Variables can be selected by filtering on the basis of their variable importance
(VIMP). For each bootstrap sample, 37% of the data are excluded on average. Thus, for a
given tree, certain individuals will have been left out of the training data. Prediction error
and variable importance is estimated from these 'out-of-bag' (OOB) data.
The OOB data.is used to estimate the importance of particular variables by
randomly permuting the values of that variable and testing whether these permutations
adversely affect the predictive ability of trees in classifying the OOB data. If randomly
permuting values of a particular variable does not affect the predictive ability of trees on
OOB samples, that variable is assigned a low importance score. Conversely, if randomly
permuting the values of a particular variabledrastically impairs the ability of trees to
correctly predict the survival time of the OOB samples, then the importance score of that
variable will be high.

3.3.4 Minimal depth selection
Minimal depth variable selection method differs from the traditional method of
variable selection in RSF, which has been based on variable importance measures
(Ishwaran et aI., 2011). Minimal depth assesses the predictive ability of a variable by its
depth relative to the root node of a tree. To determine the minimal depth, first define the
maximal subtree for a variable vas the largest subtree whose root node is split using v (the
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first-order maximal subtree). The shortest distance from the root of the tree to the root of
the closest maximal subtree of v is the minimal depth of v. The minimal depth can be
considered as the minimal number of nodes crossed from the root node, until a split
involving v is encountered. A smaller value corresponds to a more predictive variable.
In high-dimensional settings, the distribution of the minimal depth can be used as
a means to screen unimportant variables. The mean of the minimal depth distribution
represents a threshold value for selecting variables, such that those variables with forest
averaged minimal depth exceeding the mean minimal depth threshold are classified as
noisy and removed from the final model.
The concept of maximal subtrees can be extended to second-order subtrees, to
provide a powerful tool for identifying relationships between variables. A second-order
maximal (w, v)-subtree is a maximal w-subtree within a maximal v-subtree for a variable v.
In this way, we can quantify the association between two variables. Two-way interactions
can be estimated by using forest averaged second-order maximal subtrees.

3.4 Breast Cancer Data
The genetic data usedin this thesis come from 441 specimens collected between
1989 and 1998 fromCaucasian women selected from the Hormone Receptor Laboratory
(HRL) Biorepository and Tumor Marker Database (TMD)(Kidd et aI., 2010). Human
tissue specimens were collected from 235 node-negative and 206 node-positive patients.
The HRL Biorepository and the TMD contain de-identified specimens of breast
carcinoma with associated tumor clinical outcome with up to 15 years of follow-up.
Clinico-pathological data, such as tumor-based properties (e.g., pathology, grade, stage,
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SIze, tumor maker status), patient-related characteristics (e.g., age, race, menopausal
status, family history, nodal status), and clinical follow-up (e.g., treatment regimen, DFS,
OS) was available. Biochemical data, such as estrogen/progesterone receptor, epidermal
growth factor receptor, and human epidermal growth factor receptor status were obtained
from TMD.
DNA was isolated from this tissue using the AllPrep DNAIRNAlProtein Mini Kit
(Qiagen, Valencia, CA) or QIAamp DNA Mini Kit (Qiagen). Thirteen angiogenesisrelated SNPs with minor allele frequency >0.05 were selected for our genetic analysis. In
Table 1, we list the gene names, RefSNP (rs) numbers, and nucleotide change
information for these thirteen SNPs.

TABLE l.Selected SNPs in the angiogenesis pathway and their nucleotide change
Gene
IL10 1082
IL10 819
IL10 592
IL-1OR 109
TGFbl 896
TGFbRl 195
VEGF 2578
VEGF 1154
VEGF 634
VEGFR 889
VEGFR 1416
VEGFR.IVS25 92
VEGFR.IVS6_54

rs Number
rs1800896
rs1800871
rs1800872
rs9610
rs1982073
rs868
rs699947
rs1570360
Rs2010963
rs2305948
rsI870377
rs1531289
rs7692791

Nucleotide change
G>A
C>T
C>A
G>A
T>C
A>G
C>A
A>G
G>C
G>A
T>A
G>A
A>G

3.5 Missing values
Our approach for treating missing data in Lasso, Elastic Net, and Survival MDR
methods was to plug in the most frequent genotype for each SNP for the subjects with
17

missing values. RSF uses an adaptive tree imputation algorithm to adaptively impute
missing values as the tree is grown. Missing data are imputed by using a set of randomly
drawn observations from the set of non-missing in-bag data within the current node
(Ishwaran et aI., 2008).

18

CHAPTER IV
RESULTS

4.1 Penalized Cox regression models

In order to fit penalized Cox regression models, we treat the 13 SNPs as
categorical factors. For each of the 13 SNPs there are three different genotypes each with
associated indicator variables, resulting in a total of 39 potential main effect terms. We
describe k-way (k= 1,2,3) interaction models that capture the relationship between k genes
and the survival outcome. One-way interaction models include only main effect terms,
while two-way interaction models include both main effects and all two-way interaction
terms, and three-way interaction models include all main effect, two-way interaction, and
three-way interaction terms. These full models are used as starting points for fitting the
penalized regression models, which will eliminate some proportion of the terms
depending on the magnitude of the shrinkage coefficient(s).

4.1.1 L1-penalized Cox regression

Table 2 summarizes the optimal tuning parameter A, and corresponding crossvalidated log likelihood value based on the Lasso method, for the main effect, two-way,
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and three-way interaction models. As these results show, for each model there's an
optimal tuning parameter ~ and a cross-validated log likelihood value.
TABLE 2.0ptimal tuning parameter for Lasso method

CV LL,

Main effect
Two-way
Three-way
cross-validated log likelihood

14.741
10.802
10.510

CVLL
-813.657
-812.737
-812.471

In Table 3, we summarize the selected one-, two-, and three-way models based on
the Lasso method by listing the corresponding coefficients. To determine the most
important SNPs for each model, we rank the coefficients by their absolute magnitude,
with the largest magnitude coefficients ranked the highest. For the main effect model, no
SNPs were included in the model. An interaction between ILI0R_109_G/A and
TGFBRl_195_NA is selected as the most important coefficient from the two-way
interaction model, and an interaction among VEGF_2578C/C, VEGFR_889G/G and
VEGFR_1416TIT is the strongest coefficient from the three-way interaction model.

TABLE 3.Selected models based on Lasso method
SNP
MainEffect
VEGF_2578C/C
ILl OR_1 09GIA:TGFBR 1_195NA
VEGF_2578C/C: VEGFR_1416TfT
VEGFR.IVS25 _92G/G: VEGFR.IVS6_54NG
ILlOR_109G/G:VEGF_1154G/G:VEGFR_1416TfT
VEGF 2578C/C:VEGFR 889G/G:VEGFR 1416TfT
Results are presented as coefficients.
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Two-way
0.026
-0.235
0.048
-0.140
0.026

Three-way
-0.247
-0.149
0.024

In Figure 3, we plot the survival curves for the high-risk versus low-risk
genotypes based on the Lasso two-way and three-way models. For this method, we divide
genotypes into high or low risk groups based on linear predictors. For each linear
predictor, if its value exceeds the median of all linear predictors, then it is considered
high-risk. Otherwise, it is considered low-risk.
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Fig.3 Kaplan-Meier survival curve for high and low risk groups based on Lasso two-way
and three-way models

4.1.2 Elastic Net
Table 4 summarizes the optimal tuning parameters ~ and ~

I

and the

corresponding cross-validated log likelihood values based on the Elastic Net method for
the main effect, two-way, and three-way interaction models.
In Table 5, we summarize the top one, two, and three-way models identified by

the Elastic Net. VEGF_2578_C/C is selected as the most important for main effects. A
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combination of ILlOR_109_G/A and TGFBRI_195_NA is selected as the most
important two-way model. This combination is also selected as the most important threeway model.

TABLE 4.0ptimal tuning parameter for Elastic Net method
CVLL
8.031
Main effect
Two-way
11.068
Three-way
13.531
CVLL , cross-validated log likelihood

-813.413
-813.461
-813.561

0.01
0.0001
0.0001

TABLE 5.Selected models based on Elastic Net method
SNP

MainEffect

Two-way

ILlOR_109GIA
ILl OR_109GIG
VEGF_2578C/C
VEGFRIVS25_92GIG
VEGFRIVS6_54A1G
IL lOR_1 09GIA:TGFBRl_195A1A
VEGF_2578C/C:VEGFR_1416TIT
VEGFRIVS25 92GIG:VEGFR.IVS6 54A1G

-0.063
0.027
0.167
-0.047
-0.047

0.023

-0.224
0.035
-0.131

Three-way

-0.132
-0.045

Results are presented as coefficients.

In Figure 4, we plot the survival curves for the high-risk versus low-risk
genotypes defined by Elastic Net method. We divide genotypes into high or low risk
groups based on linear predictors.
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Fig.4 Kaplan-Meier survival curves for high and low risk groups based on Elastic Net
one-, two-, and three-way models.

4.2 Survival MDR
For the main effects, two-way and three-way interaction combinations, the best
models are shown in Table 6. The VEGF_2578 has the highest cross-validation
consistencies (60%) of the one factor model , and is therefore selected as the final best
models. A combination between ILI0R_109 and TGFBR1_195 serves as the best two
factor predictors, with a cross validation consistency of 50%. Lastly, a combination
among IL 1OR_109, TGFBR L 195 and VEGF_2578 serve as the best three factor model
with a cross validation consistency of 40%. One curious result is that a main effect model
(VEGFR.IVS25_92) appears amongst the list of models for both the two-way and threeway interaction evaluations, with a

eve

of 10% in each case.

determine why this single factor model appeared in each case.

TABLE 6.Selected models based on Survival MDR method
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We are unable to

SNP

MainEffect

60%
VEGF_2578
20%
VEGFRIVS25_92
20%
VEGFR.IVS6_54
ILI0R_I09 :TGFBR1_195
ILIOR_109:VEGF_1154
ILI0R_109:TGFBR1_195:VEGF_2578
ILIOR_109 :TGFBR1_195:VEGF_1154
ILIOR_109:VEGF_1154:VEGFR_1416
VEGF_2578 :VEGFRIVS25 _92:VEGFRIVS6_54
VEGF 1154:VEGFR.IVS25 92:VEGFRIVS6 54
Results are presented as cross-validated consistency (eve).

Two-way

Three-way

10%

10%

50%
40%
40%
20%
10%
10%
10%

Every genotype is assigned into an appropriate group (high / low risk) by Survival
MDR's constructive induction algorithm. Based On this, we constructed Kaplan-Meier
plots of the high and low risk groups determined by the best one-, two-, and three-way
models (Figure 5).

One-way

Two-way

Three-way

I

Fig.5 Kaplan-Meier survival curve for high and low risk groups based on Survival MDR
one-, two-, and three-way models.

4.3 Random Survival Forest
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Table 7 gives the average VIMP scores and minimal depth thresholds for each
SNP based on 50 independent runs of RSF with mtry equal to 1000. Both the VIMP and
minimal depth selection methods select ILlOR_109 as the most important main effect.
The second order minimal depth values for each SNP relative to the other SNPs were
calculated, and these values were used to define a distance matrix between the SNPs.
Figure 6 plots the resulting dendrogram based on hierarchical clustering of the data.
SNPs ILIO_1082 and ILlOR_109 are joined together first based on the hierarchical
clustering, and indicated a possible strong interaction between the SNP pair.

TABLE 7.Selected models based on Random Survival Forest method

VIMP
Variable
ILlOR_109
VEGF_2578
VEGF_634
VEGF_1154
TGFBRl_195
TGFBl_896
ILl 0_592
VEGFR.IVS6_54
VEGFRIVS25 _92
VEGFR_1416
ILl 0_1082
VEGFR_889
ILlO 819

Average
0.035
0.014
0.011
0.009
0.009
0.006
0.003
0.002
0.000
-0.002
-0.004
-0.005
-0.007

Minimal Depth
Variable
Average
ILlOR_109
0.043
VEGF_2578
0.015
VEGF_634
0.014
TGFBRl_195
0.013
TGFB1_896
0.009
VEGF_1154
0.005
ILl 0_592
0.002
VEGFR_1416
0.002
VEGFRIVS6_54
-0.002
ILl 0_1082
-0.004
ILlO_819
-0.005
VEGFR_889
-0.005
VEGFRIVS25 92
-0.005

Rank
1.00
2.68
3.54
4.42
4.84
5.96
7.46
7.54
8.94
9.92
10.92
11.46
12.32
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Rank
1.00
3.07
3.23
3.44
4.83
6.45
7.32
7.56
9.52
10.69
11.13
11.25
11.51

Cluster Dendrogram
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Fig.6 Variables clustered by second-order minimal depth

4.4 Comparison of Results

As shown in Tables 8, 9, and 10, we list the two most important SNPs from the
one, two, and three-way models identified by Lasso, Elastic Net, and Survival MDR.
Also given are the most important SNPs based on the VIMP and minimal depth from
RSF, and the most significant two-way interaction identified by minimal depth using
second-order maximal subtrees. In Figure 8, we put the Kaplan-Meier survival curves
based on the Lasso, Elastic Net and Survival MDR methods together.
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Table 8. Comparison table of significant variables selected by different methods based
on main effect models.
Method
Lasso

Main Effect

Elastic Net

VEGF_2578C/C
ILlOR_109G/G

SurvivalMDR

VEGF_2578/ VEGFR.IVS25_92
VEGFR.IVS6_54

VlMP

ILlOR_109
VEGF_2578

MinimalDepth

ILlOR_109
VEGF_2578

Table 9. Comparison table of significant variables selected by different methods based
on two-way models.
Method
Lasso

Two-way
ILl OR_109G/A:TGFBR 1 195A1A
VEGFRIVS25 _92G/G: VEGFR.IVS6_54A1G

Elastic Net

ILlOR_109G/A:TGFBRC195A1A
VEGFRIVS25 _92G/G: VEGFRIVS6_54A1G

SurvivalMDR

ILlOR_109: TGFBRl_195
ILlOR_109: VEGF_1154

VlMP

ILl O_1082:ILlOR_109
VEGF_634:VEGFR.IVS6_54

MinimalDepth
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Table 10. Comparison table of significant variables selected by different methods based
on three-way models.
Three-way

Method
Lasso

ILIOR_109G/A:TGFBRl 195A1A
VEGF_2578C/C: VEGFR_889G/G :VEGFR_1416TIT

Elastic Net

ILlOR_I09G/A:TGFBR1_195A1A
VEGFR.IVS25 _92G/G :VEGFR.IVS6_54A1G

SurvivalMDR

ILlOR_109: TGFBRl_195: VEGF_2578
ILIOR_109:TGFBRl_195.:VEGF_1154

VIMP

MinimalDepth

One-way

Two-way

Three-way
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Fig. 8 Kaplan-Meier survival curve for high and low risk groups based on Lasso, Elastic
Net, and Survival MDR methods.

VIMP

Minimal Depth

0

0

~

~

-~.

'"

'"
0

0

;;-

;;-

>.
ell

~
I

IlJ

C

0

~

.0

'is

'"6

'"

.0

£

£

.
j

~

1<l

~

0

'"
0

""\,
"\
-""
"

--.--,...

~

- '+,

.......

..

' ' + , - -:. .......... ...- ..........

0

U)

N

N

0

0

0
0

1

50

low nsk group

-- - - High fisk group

100

0
0

150

1

50

Months from DiagnosIs

low nsk gfOl4)
---- HIgh fisk group

100

150

Months from DII!gnosis

Fig. 9 Kaplan-Meier survival curve for high and low risk groups based on VIMP and
minimal depth one-way models

In Figure 9, we plot the Kaplan-Meier survival curves for high and low risk
groups based on the VIMP and minimal depth models . In this situation, we separate high
or low risk groups according to VIMP score and mean minimal depth threshold. We use
median as the threshold. Note that, as opposed to the other methods, there are no
additional two- and three-way interaction models for the RSF method. This is because
RSF already implicitly includes interactions, in the sense that second-order maximal
(w, v)-subtrees identify interactions between two variables wand v.
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CHAPTER V
DISCUSSION

In the current study, we directly compared the performance of four variable
selection techniques for detecting SNP-SNP interactions in survival genetic association
studies: the Lasso and Elastic Net penalized Cox regression models, Survival Multifactor
Dimensionality Reduction, and Random Survival Forest. As shown in the previous
section, we demonstrate that all these methods can detect the presence of multiplicative
interaction models even when the main effects are not statistically significant. All of the
plots shown in the previous section indicate the significant SNPs chosen by these four
methods separate the two survival curves, although the statistical significant of this
separation was not evaluated.
Among the four methods, the Lasso and Elastic Net are semi-parametric methods.
The Elastic Net performed very similarly to the Lasso in our study, particularly for the
two-, and three-way interaction models. Both methods select the same top two most
important terms in each case. But the additional L2 -penalty for the Elastic Net distributes
the weight to more variables, so that the Elastic Net selected more variables overall
compared to the Lasso. This is especially useful in the situation of high correlation. When
high correlation exists, the Lasso will only pick one of the correlated variables, whereas
the Elastic Net will select the entire set of correlated variables. Thus, it is not surprising
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to see that the Lasso selected no main effect terms, whereas five SNPs were
selected using the Elastic Net. A limitation of these two methods is that they constructed
and selected variables corresponding to individual genotypes, rather than selecting the set
of genotypes corresponding to a particular SNP. This shortcoming can be overcome by
extending the group Lasso to survival time data (Meier et aI., 2008; Winham et aI., 2011).
In contrast, Survival MDR and Random Survival Forest are non-parametric
methods. The potential advantage of Survival MDR over parametric methods lies in
determining high and low risk groups for genotype combinations regardless of whether
linear relationships exist between survival time and SNP effects. A limitation of Survival
MDR is that it does not have a way to adjust for covariate effects such as gender, family
history, and smoking status. In terms of Random Survival Forest, it is highly data
adaptive and its computation is fast even for very large data sets. It can adaptively impute
missing data as a tree is grown using its own missing data algorithm. This might cause
difference between the result of RSF and other methods since they are using different
ways in imputing missing values. As shown in the previous section, both the Elastic Net
and Survival MDR select VEGF_2578 C/C as the most important main effect term.
However, both the VIMP and minimal depth choose ILlOR_109 as the most important
main effect. Different results also show up in the situation of the most important two-way
interactions.
In recent years, some researchers have attempted to evaluate the performance of
different approaches to analyze high-dimensional data with respect to a survival endpoint.
Benner and Zucknick (Benner et aI., 2010) implemented the Lasso, Elastic Net, adaptive
Lasso, and smoothly clipped absolute deviation (SCAD) methods into the model building
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process when analyzing high-dimensional data with the Cox proportional hazards model.
They demonstrated that the Lasso and also Elastic Net performed the best in terms of
prediction accuracy, and thus recommended to use those approaches in actual data
application. Winham (Winham et aI., 2011) compared the performance of MDR, the
traditional Lasso with LJ penalty, and the group Lasso for categorical data with groupwise LJ penalty to detect gene-gene interactions. Unlike Benner, they evaluated the
predictive performance using a broad range of simulations. They found that the
performance of each method is context dependent. Thus, they concluded that each
approach might be best suited for detecting and characterizing interactions with different
mechanisms. Similarly to Winham, we found differences between the methods when
identifying the most prognostic relevant covariates.
While this study is useful for informing researchers about different analysis tools
for identifying SNP-SNP interactions, it is not a fully comprehensive comparison. In
order to definitely guide researchers in how to choose an analysis method for real data
application, prediction error for each method on independent test data should be provided.
In addition, various difficulties in real data such as missing values and genetic
heterogeneity should be incorporated into the comparison. Additional methods not
investigated here may prove even more fruitful for identifying SNP-SNP interactions.
For example, the adaptive Lasso has proved a promising technique with attractive
theoretical properties. We anticipate that these methods will be used to find interactions
among covariate effects, in addition to genotypes. We also anticipate comparing the
performance of these methods to detect gene-gene interactions through simulations.
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In summary, we compared and contrasted the performance of four variable
selection approaches to identify epistatic interactions between SNPs using survival data
for breast cancer patients. While we have not conducted a comprehensive comparison in
order to determine which method(s) performed the best for indentifying interactions, each
method has potential for application to high-dimensional genetic interaction data with
survival outcomes ..
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APPENDIX
R code for data management
## Reading in Breast Cancer Data
breastcancer<read.csv("E:/STUDYITHESIS/BRCADataForDartmouthlBRCADataForDartmouth.csv",
header=T)
names(breastcancer)
## Create Partial Dataset 'breastca'
## Contains only 14 genes & survival time(OS) & event(dod.ind)

breastca<- breastcancer[,c(2: 15)]
breastca$time<- breastcancer$OS
breastca$event<- breastcancer$dod.ind
names(breastca)
length(breastca[, 1]) # 441
## Impute Missing Value
## Remove the rows that contain missing values in 'time' and 'event'
## Remove the rows contain missing values in 'dod.ind'
brca<- breastca
head(brca)
which(is.na(brca$event» # 97 265 316 345
brca<- brca[ -c(97 ,265,316,345),]
## Check result
length(breastca[, 1])
length(brca[, 1])
tabIe(brca$event)
## Remove the rows contain missing values in 'time'
which(is.na(brca$time» # 375
brca<- brca[ -375,]
table(brca$time) # Check result
length(brca[, 1]) # 436
## Remove the rows that time=O

which(brca$time== 0) # 123 380
brca<- brca[ -c(l23,380),]

length(brcaL 1]) # Check result 434
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## Assign all missing samples using the most common genotype
brca.mean[, 1] [which(is.na(brca.mean[, 1))) ]<-geno
table(brca.mean[,I])
## Try to use a LOOP through all the genes (1-14)
for(i in 1: 14){
tab<- table(brca.mean[,i))
geno<- names( tab) [which.max( table(brca.mean[,i)))]
brca.mean[,i] [which(is.na(brca.mean[,i)))]<-geno

##brca.mean # Check the result
length(brca.mean[, 1]) #434
## Convert I st Dataset Factors to Numbers
########################################################################
## Create separate data.frame called 'numeric brca'
## Levels should be 0, 1,2 (1= heterozygote,O= most common homozygous)
numeric.brca.mean<- brca.mean
names(numeric. brca.mean)
## "IL1O_1082"
length(which(is.na(numeric.brca.mean[,I]))) # Check again
tab1e(numeric.brca.mean[,I])
## AlA AlG GIG
## 116 201 11 7
numeric.brca.mean[,I]<ifelse(numeric.brca.mean[, 1]%in% "AlG", 1,ifelse(numeric.brca.mean[, 1]%in% "GIG" ,0,2))
table(numeric.brca.mean[, 1]) # check result
## "IL1O_819"
table(numeric.brca.mean[,2])
## C/C CIT TIT
## 304109 21
numeric.brca.mean[,2]<ifelse(numeric.brca.mean[,2]%in% "CIT", 1,ifelse(numeric.brca.mean[,2]%in% "C/C" ,0,2))
table(numeric.brca.mean[,2)) # check result

table(numeric.brca.mean[,3])

## AlA AlC C/C
## 13 117304
numeric.brca.mean[,3]<ifelse(numeric.brca.mean[,3]%in%"AlC",I,ifelse(numeric.brca.mean[,3]%in%"C/C",0,2))
tab1e(numeric.brca.mean[,3]) # check result
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## "ll...1OR_241"
table(numeric.brca.mean[,4])
## AlA AlG GIG
## 58148228
numeric.brca.mean[,4]<ifelse(numeric.brca.mean[,4]%in%"AlG",I,ifelse(numeric.brca.mean[,4]%in%"GIG",O,2»
table(numeric.brca.mean[,4]) # check result
## "ll...1OR_109"
table(numeric.brca.mean[,5])
## AlA GIA GIG
## 74216144
numeric .brca.mean [,5]<ifelse(numeric.brca.mean[,5]%in%"GIA",I,ifelse(numeric.brca.mean[,5]%in%"GIG",O,2»
table(numeric.brca.mean[,5]) # check result
## "TGFB 1_896"
table(numeric.brca.mean[,6])
## C/C CIT TIT
## 35236163
numeric.brca.mean[,6]<ifelse(numeric.brca.mean[,6]%in%"CIT",I,ifelse(numeric.brca.mean[,6]%in%"TIT",O,2»
table(numeric.brca.mean[,6]) # check result
## "TGFBR1_195"
table(numeric.brca.mean[,7])
## AlA AlG GIG
## 286132 16
numeric.brca.mean[,7]<ifelse(numeric.brca.mean[,7]%in%"AlG",I,ifelse(numeric.brca.mean[,7] %in% "AlA",O,2»
table(numeric.brca.mean[,7]) # check result

## "VEGF_2578"
table(numeric.brca.mean[,8])

## AlA CIA C/C
## 85216 133
numeric.brca.mean[,8]<ifelse(numeric.brca.mean[,8]%in%"C/A",I,ifelse(numeric.brca.mean[,8]%in%"C/C",O,2»
table(numeric.brca.mean[,8]) # check result
## "VEGF_1154"
table(numeric.brca.mean[,9])
## AlA AlG GIG
## 24152258
numeric.brca.mean[,9]<ifelse(numeric.brca.mean[,9]%in%"AlG",I,ifelse(numeric.brca.mean[,9]%in%"GIG",O,2»
table(numeric.brca.mean[,9]) # check result
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## "VEGF_634"
table(numeric.brca.mean[, 10])
## C/C G/C GIG
##53217164
numeric.brca.mean[,l0]<ifelse(numeric.brca.mean[, 1O]%in%"G/C", 1,ifelse(numeric.brca.mean[, 1O]%in%"G/G" ,0,2»
table(numeric.brca.mean[,lO]) # check result
## "VEGFR_889"
table(numeric.brca.mean[,ll])
## AlA AlG GIG
## 5 81 348
numeric.brca.mean[,11]<ifelse(numeric.brca.mean[,II]%in%"AlG",I,ifelse(numeric.brca.mean[,11]%in%"G/G",0,2»
table(numeric.brca.mean[,11]) # check result
## "VEGFR_1416"
table(numeric.brca.mean[,12])
## AlA T/A TIT
## 17 120297
numeric.brca.mean[,12]<ifelse(numeric.brca.mean[, 12]%in%"T/A", l,ifelse(numeric .brca.mean[,12]%in%"TIT",0,2»
table(numeric.brca.mean[,12]) # check result
## "VEGFR.lVS25_92"
table(numeric.brca.mean[,13])
## AlA G/A GIG
##31127276

numeric.brca.mean[,13]<ifelse(numeric.brca.mean[, 13]%in%"GIA", 1,ifelse(numeric.brca.mean[, 13]%in%"G/G" ,0,2»
table(numeric.brca.mean[, 13]) # check result
## "VEGFR.IVS6_54"
table(numeric.brca.meanLI4])
## AlA AlG GIG
## 133217 84
numeric.brca.meanL 14]<ifelse(numeric.brca.mean[, 14]%in% "AlG", 1,ifelse(numeric.brca.mean[, 14]%in%"AlA" ,0,2»
table(numeric.brca.mean[,14]) # check result
head(numeric.brca.mean) # Check Convertion

## remove snps that fail HWE

"ll.., 1OR_241 "

brca<- read.csv("brca.csv")
names(brca)
brca<- brca[,-c(1,5)]
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brca.mean<- read.csv("brca.mean.csv")
names(brca.mean)
brca.mean<- brca.mean[,-c( 1,5)]
numeric.brca.mean<- read.csv("numeric.brca.mean.csv")
names(numeric.brca.mean)
numeric.brca.mean<- numeric.brca.mean[,-c( 1,5)]

R code for Lasso method
li brary(penalized)
library(survival)
set.seed(l 0 1)
## main effects
########################################################################
optl <- optLl (Surv(brca.mean$time, brca.mean$event) - ., data = brca.mean[l: 13], fold=lO)
optl$lambda # 14.74060
optl$ cvl #cross-validation likelihood= -813.6569
## Search for best one way model

fitl <- penalized(Surv(brca.mean$time, brca.mean$event) - ., data = brca.mean[l: 13],
lambdal =14.74060, lambda2 = 0)
coefficients(fitl )
## two way interactions
########################################################################
opt2 <- optLl(Surv(brca.mean$time, brca.mean$event) - .1\2, data = brca.mean[I:13], fold=lO)
opt2$lambda # 10.80183
opt2$ cvl #cross-validation likelihood= -812.7365
## Search for best two way model
fit2 <- penalized(Surv(brca.mean$time, brca.mean$event) - .1\2, data = brca.mean[ 1: 13],
lambdal = 10.80183, lambda2 = 0)
coefficients( fit2)
## three way interactions
########################################################################
opt3 <- optLl(Surv(brca.mean$time, brca.mean$event) - .1\3, data = brca.mean[l: 13], fold=lO)
opt3$ lambda # 10.51043
opt3$ cvl # -812.4712
## Search for best three way model
fit3 <- penalized(Surv(brca.mean$time, brca.mean$event) - .1\3, data = brca.mean[l: 13],
lambdal = 10.51043, lambda2 = 0)
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coefficients( fit3)
## Lasso KM curve based on three-way model
## divide patients into lowlhigh risk based on linear predictor

slotNames( fit3)
lp<- linear.predictors(fit3)
Ip.50 <- median(lp)
lp.low.high<- ifelse(lp<= Ip.50, 0, 1)
fit.1p.2grps <- survfit(Surv(brca.mean$time, brca.mean$event) - lp.low.high)
plot(fit.1p.2grps, main="Lasso KM curve based on three-way model", xlab = "Months from
Diagnosis", ylab="Survival Probability", lty=I:2, cex=0.5)
legend("bottomright", c("Low risk group", "High risk group"), Ity=I:2)

R code for Elastic Net method
library(penalized)
library(survival)
set.seed( 101)
## Use lambda2= {0.0001, 0.001, 0.01, 0.1,1, 1O}
## main effects
########################################################################
## Find optimal lambda 1 and lambda2

optlambda<- function(i){
lambda2storage<- matrix(nrow = 6, ncol = 1)
lambda2storage[,]<- c(O.OOOI, 0.001, 0.01, 0.1, 1, 10)
rownames(lambda2storage)<- seq(l :6)
cvlstorage<- matrix(nrow = 6, ncol = 2)
set. seed(l 00+ i)
idx<- sample(l :434,434, replace=FALSE)
snps.perm<- brca.mean[idx,l: 13]
snps.perm$time<- brca.mean$time
snps.perm$event<- brca.mean$event
for (j in 1:6){
opt<- optL1(Surv(time, event) - ., data=snps.perm, lambda2 = lambda2storage[j],
fold=lO)
cvlstorage[j,I]<- opt$cvl
cvlstorage[j,2]<- opt$lambda
k<- which.max(cvlstorage[,l])
lambda2<-lambda2storage[k]
lambdal<- cvlstorage[k,2]
retum(list(lambdaI=lambdal,lambda2=lambda2,cvl=cvlstorage[k,I]»

opt 1<-optlambda( 1)
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optl
fitt <- penalized(Surv(brca.mean$time, brca.mean$event) - ., data = brca.mean[ 1: 13],
lambdal = 8.0312, lambda2=0.01 )
coefficients( fit 1)

## Interactions: _.A2
########################################################################

optlambda2<- function(i){
lambda2storage<- matrix(nrow = 6, ncol = 1)
lambda2storage[,]<- c(O.OOOI, 0.001, 0.01, 0.1, 1, 10)
rownames(lambda2storage)<- seq(l:6)
cvlstorage<- matrix(nrow = 6, ncol = 2)
set.seed( 100+i)
idx<- sample(l:434, 434, replace=FALSE)
snps.perm<- brca.mean[idx,l: 13]
snps.perm$time<- brca.mean$time
snps.perm$event<- brca.mean$event
for (j in 1:6){
.A2,
opt<- optLl (Surv(time, event)
lambda2storage[j], fold=lO)
cvlstorage[j,I]<- opt$cvl
cvlstorage[j,2]<- opt$lambda

data=snps.perm,

lambda2

k<- which.max(cvlstorage[,l])
lambda2<- lambda2storage[k]
lambdal<- cvlstorage[k,2]
retum(list(lambda1 =lambdal ,lambda2=lambda2,cvl=cvlstorage[k, 1])

opt2< -optlambda2( 1)
opt2
## optimal parameters: lambdal = 9.053774, lambda2=0.0001
fit2 <- penalized(Surv(brca.mean$time, brca.mean$event) - .A2, data = brca.mean[I:13],
lambdal = 11.06831, lambda2=0.0001 )
summary(fit2)
coefficients( fit2)

## Interactions: _.A3
########################################################################

optlambda3<- function(i){
lambda2storage<- matrix(nrow = 6, ncol = 1)
lambda2storage[,]<- c(O.OOOI, 0.001, 0.01, 0.1, 1, 10)
rownames(lambda2storage )<- seq( 1:6)
cvlstorage<- matrix(nrow = 6, ncol = 2)
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=

set.seed(lOO+i)
idx<- sample( 1:434, 434, replace=FALSE)
snps.perm<- brca.mean[idx,1:13]

snps.perm$time<- brca.mean$time
snps.perm$event<- brca.mean$event
for Gin 1:6){
opt<- optL1(Surv(time, event)
lambda2storage[j], fold=lO)
cvlstorage[j,l]<- opt$cvl
cvlstorage[j,2]<- opt$lambda

.1\3,

data=snps.perm,

lambda2

=

k<- which.max(cvlstorage[,l])
lambda2<-lambda2storage[k]
lambdal<- cvlstorage[k,2]
retum(list(lambda1 =lambdal ,lambda2=lambda2,cvl=cvlstorage[k, 1]))

## lambda3<- optlambda3(l)
fit3 <- penalized(Surv(brca.mean$time, brca.mean$event) - .1\3, data = brca.mean[l:13],
lambda1 = 13.53075, lambda2=le-04)
coefficients( fit3)

## Elastic Net KM curve based on three-way model
########################################################################slotNa
mes(fit)
Ip<- linear.predictors(fit3)
Ip.50 <- median(lp)
Ip.low.high<- ifelse(lp<= Ip.50, 0, 1)
fit.lp.2grps <- survfit(Surv(brca.mean$time, brca.mean$event) - Ip.low.high)
plot(fit.lp.2grps,main="Elastic Net KM curve based on three-way model", xlab = "Months from
Diagnosis", ylab="Survival Probability", lty=1:2, cex=0.5)
legend("bottomright", c("Low risk group", "High risk group"), lty=l :2)

R code for Survival MDR method
## Survival MDR use data 'numeric.brca.mean'
source("Surv-MDR.R")
set. seed(l 0 1)
## Search for the best one-way model
ffit1 <- ssimucross(numeric.brca.mean[l: 13],numeric.brca.mean$time,
numeric.brca.mean$event, lO, 1)
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table(ffit 1$index)
## 7 12 13
## 6 2 2
colnames(numeric.brca.mean)[c(7,12,13)] # "VEGF_2578" "VEGFR.lVS25_92"
"VEGFR.IVS6_54"
## Search for the best two-way model
ffit2 <- ssimucross(numeric.brca.mean[l: 13],numeric.brca.mean$time,
numeric.brca.mean$event, 10,2)
table(ffit2$index)
## 12406408
## 1 5 4
colnames(numeric.brca.mean) [c(4,6,8)] # "ILlOR_109" "TGFBR1_195" "VEGF_1154"
## Search for the best three-way model
ffit3 <- ssimucross( numeric. brca.mean [1 : 13] ,numeric. brca.mean$time,
numeric.brca.mean$event, 10,3)
ffit3
table(ffit3$index)
## 12406074060840811 71213 81213
##142 1 1 1
colnames(numeric.brca.mean)[c(8, 12, 13)]

R code for RSF method
## VIMP variable selection, get VIMP scores
########################################################################
## Fit RSF using 50 different seed values
## Use for loop, change seed each time, keep VIMP scores

library("randomSurvivaIForest")
ntree<- 1000
set. seed( 101)
## use log-rank splitting rule, which is the default splitting rule
## use data-imputting (redo 50 repeats using na.impute (but not for poster)

brca.out<- rsf(Survrsf(time, event)-.,brca,ntree=ntree, na.action="na.impute")
brca.out$importance
names(brca)
sort(brca.out$importance, decreasing=TRUE)

## VIMP KM curve based on one-way model

brca.out$mortality
q50.mort <- median(brca.out$mortality)
split.rsf<- ifelse(brca.out$mortality> q50.mort, 1, 0)
library(survival)
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fit.km <- survfit(Surv(brca$time, brca$event) - split.rsf)
plot(fit.km, main="VIMP KM curve based on one-way model", xlab = "Months from
Diagnosis", ylab="Survival Probability", Ity=1:2, cex=0.5)
legend("bottomright", c("Low risk group", "High risk group"), Ity=I:2)
B <- 50
VIMP <- matrix(NA, nrow = 13, ncol = B)
rownames(VIMP) <- names(brca)[ 1: 13]

for (i in 1:B) {
brca.multi<- rsf(Survrsf(time, event)-.,brca,ntree=ntree,
seed=( 1OO+i),na.action="na.impute ")
VIMP[,i] <- brca.multi$importance
}
VIMP.mean<- rowMeans(VIMP)
VIMP.mean
round( sort(VIMP .mean, decreasing=TRUE),3)
rank.VIMP<- apply( -1 *VIMP, 2, rank)
rank.VIMP.mean<- rowMeans(rank.VIMP)
sort(rank.VIMP.mean)
## Minimal Depth variable selection
########################################################################

library("randomSurvivaIForest")
ntree<- 1000
nodesize<- 2
mtry<- 14*(3/4)
nsplit<- 10
brca.out<- rsf(Survrsf(time, event)-.,brca, ntree=ntree, nodesize=nodesize, mtry=mtry,

nsplit=nsplit, seed= 101 ,forest= TRUE,na.action=
"na.impute")
sort(brca.out$importance, decreasing=TRUE)
## Minimal Depth one-way Plot

brca.out$mortality
g50.mort <- median(brca.out$mortality)
split.rsf<- ifelse(brca.out$mortality> g50.mort, 1, 0)
library(survival)
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fit.km <- survfit(Surv(brca$time, brca$event) - split.rsf)
plot(fit.km, main="Minimal Depth KM curve based on one-way model", xlab = "Months
from Diagnosis", ylab="Survival Probability", Ity=1:2, cex=0.5)
legend("bottomright", c("Low risk group", "High risk group"), lty=1:2)
## Minimal Depth two-way Plot
########################################################################
###

brca.out<- rsf(Survrsf(time, event)-.,brca, ntree=ntree, nodesize=nodesize, mtry=mtry,
nsplit=nsplit, seed= 101 ,forest= TRUE,na.action=
"na.impute")
max.out2 <- max.subtree(brca.out, max.order = 2, sub.order = TRUE)
dist.mat<- as.dist(max.out2$subOrder)
clust.snps<- hclust(dist.mat)
plot(clust.snps,xlab = "Months from Diagnosis", cex=l)
B <- 50
Minimal <- matrix(NA, nrow = l3, ncol = B)
Minimal.mean<- matrix(NA, nrow = 13, nco I = 1)
rownames(Minimal) <- names(brca)[I: 13]

for (i in I:B) {
. brca.multi<- rsf(Survrsf(time, event)-.,brca,ntree=ntree,nodesize=nodesize,
mtry=mtry,
nsplit=nsplit,seed=( 1OO+i),forest= TRUE,na.action= "na.impute")
Minimal[,i] <- brca.multi$importance
}

Minimal.mean<-rowMeans(Minimal)
Minimal.mean
round( sort(Minimal. mean, decreasing=TRUE ),3)
Minimal.rank<- apply( -1 *Minimal, 2, rank)
Minimal.rank.mean<- rowMeans(Minimal.rank)
sort(Minimal.rank.mean)
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